Goodwill And Other Intangible Assets

12 Months Ended

Dec. 31, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

The components of goodwill and other intangibles at December 31, 2013 and 2012, and related amortization periods for continuing operations are as follows:



(In Thousands)	2013		2012		Amortization Periods
Goodwill	$	172,788	$	176,620	Not amortized
Other identifiable intangibles:
Customer relationships (cost basis of $31,357 in 2013 and 34,135 in 2012)	25,962		31,163		10-12 years
Proprietary technology (cost basis of $18,851 in 2013 and $19,624 in 2012)	14,356		17,145		Not more than 15 years
Tradenames	12,594		13,332		Indefinite life
Non-compete agreements (cost basis of $4,154 in 2013 and 2012)	600		2,359		2 years
Total carrying value of other intangibles	53,512		63,999
Total carrying value of goodwill and other intangibles	$	226,300	$	240,619

A reconciliation of the beginning and ending balance of goodwill for each of the three years in the period ended December 31, 2013 is as follows:



(In Thousands)	2013			2012			2011
Net carrying value of goodwill, beginning of year	$	176,620		$	165,372		$	103,639
Acquisitions	—			13,695			63,214
Increase (decrease) due to foreign currency translation	(3,832		)	(2,447		)	(1,481		)
Net carrying value of goodwill, end of year	$	172,788		$	176,620		$	165,372

At December 31, 2013, the goodwill balance was $159.1 million for Film Products and $13.7 million for Aluminum Extrusions.

Amortization expense for continuing operations over the next five years is expected to be as follows:



Year	Amount (In Thousands)
2014	$	5,643
2015	4,946
2016	4,906
2017	4,906
2018	4,773

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details